chr7:87132333:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr7:87,132,333-87,342,639 |
hg38 | chr7:87,503,017-87,713,323 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.006 | squamous cell carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
0.010 | Cardiovascular Diseases | ATP binding cassette transporter 1 (ABCB1) plays a critical role in the developm... | BeFree,GAD | 25118983 | Detail |
<0.001 | celiac disease | NA | BeFree | Detail | |
0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
0.003 | Cholangitis, Sclerosing | NA | BeFree,GAD | Detail | |
<0.001 | cholestasis | NA | BeFree | Detail | |
<0.001 | chordoma | NA | BeFree | Detail | |
0.002 | Congenital chromosomal disease | NA | BeFree | Detail | |
<0.001 | colitis | NA | BeFree | Detail | |
0.054 | ulcerative colitis | Association of ABCB1 polymorphisms and ulcerative colitis susceptibility. | BeFree,GAD,LHGDN | 25755800 | Detail |
0.011 | Colonic Neoplasms | NA | BeFree,LHGDN | Detail | |
0.011 | colorectal carcinoma | Chemoresistance in multidrug-resistant (MDR) cells over expressing P-glycoprotei... | BeFree | 24901713 | Detail |
0.011 | colorectal carcinoma | Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 ge... | BeFree | 25355168 | Detail |
0.133 | Colorectal Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
0.001 | Coronary heart disease | NA | BeFree | Detail | |
0.026 | Crohn Disease | Polymorphisms of MDR1 are associated with patient's GC response and a predisposi... | BeFree,GAD,LHGDN | 25346426 | Detail |
0.009 | cystic fibrosis | NA | BeFree,GAD,LHGDN | Detail | |
0.009 | Mental Depression | NA | BeFree,GAD | Detail | |
0.002 | depressive disorder | NA | BeFree | Detail | |
0.005 | diabetes mellitus | NA | BeFree,GAD | Detail | |
0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
0.003 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD | Detail | |
0.001 | diarrhea | NA | BeFree | Detail | |
0.003 | Down syndrome | NA | LHGDN | Detail | |
0.005 | drug allergy | NA | GAD | Detail | |
0.002 | Dyskinesia, Drug-Induced | NA | GAD | Detail | |
0.080 | encephalitis | NA | RGD | Detail | |
0.003 | Endometrial Neoplasms | NA | LHGDN | Detail | |
<0.001 | Ependymoma | NA | BeFree | Detail | |
0.003 | Epilepsy, Generalized | NA | BeFree,GAD | Detail | |
<0.001 | erythema multiforme | NA | BeFree | Detail | |
0.120 | Escherichia coli Infections | NA | CTD_human | Detail | |
0.121 | Esophageal Neoplasms | NA | BeFree,CTD_human | Detail | |
<0.001 | Extrapyramidal Disorders | NA | BeFree | Detail | |
<0.001 | Fatigue | NA | BeFree | Detail | |
0.005 | Femur Head Necrosis | NA | GAD | Detail | |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
<0.001 | pathologic fistula | NA | BeFree | Detail | |
0.005 | gastritis | NA | BeFree,GAD | Detail | |
<0.001 | Gastrointestinal Diseases | NA | BeFree | Detail | |
0.012 | glioblastoma | Temozolomide induces the production of epidermal growth factor to regulate MDR1 ... | BeFree,GAD,LHGDN | 25053824 | Detail |
0.012 | glioblastoma | Taken together, we confirmed P-gp targeting of TMZ, a crucial regulator of TMZ r... | BeFree,GAD,LHGDN | 26208431 | Detail |
0.010 | Glioma | NA | BeFree,LHGDN | Detail | |
<0.001 | glomerulonephritis | NA | BeFree | Detail | |
0.005 | Graft-vs-Host Disease | NA | GAD | Detail | |
<0.001 | chronic granulomatous disease | NA | BeFree | Detail | |
0.003 | Graves Disease | NA | BeFree,GAD | Detail | |
<0.001 | Hallucinations | NA | BeFree | Detail | |
0.007 | Head and Neck Neoplasms | NA | GAD | Detail | |
0.121 | congenital heart defects | NA | BeFree,CTD_human | Detail | |
0.080 | Heart Diseases | NA | CTD_mouse | Detail | |
0.003 | Heart failure | NA | BeFree,GAD | Detail | |
<0.001 | congestive heart failure | NA | BeFree | Detail | |
<0.001 | Heart Septal Defects | Maternal medication use, fetal 3435 C>T polymorphism of the ABCB1 gene, and risk... | BeFree | 24740628 | Detail |
<0.001 | Ventricular Septal Defects | In conclusion, fetal 3435 C>T polymorphism in the ABCB1 gene increases the risk ... | BeFree | 24740628 | Detail |
<0.001 | hepatitis | NA | BeFree | Detail | |
<0.001 | hepatitis A | NA | BeFree | Detail | |
<0.001 | hepatitis B | NA | BeFree | Detail | |
0.003 | heroin dependence | NA | BeFree,GAD | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
0.083 | HIV Infections | NA | BeFree,GAD | Detail | |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
<0.001 | HTLV-I Infections | NA | BeFree | Detail | |
0.005 | Hyperbilirubinemia | NA | BeFree,GAD | Detail | |
0.012 | Hypercholesterolemia | NA | BeFree,GAD | Detail | |
<0.001 | Hypercholesterolemia, Familial | The mRNA expression and function of OATP1B1, ABCB1 and ABCG2 were assessed in pe... | BeFree | 25084202 | Detail |
0.002 | Hyperlipidemia | NA | GAD | Detail | |
0.011 | Hypertensive disease | We hypothesized that the C(3435)T polymorphism in MDR-1 could be associated with... | BeFree,GAD | 23161145 | Detail |
0.011 | Hypertensive disease | Recent data indicate that enzymes and transporters involved in CNI pharmacokinet... | BeFree,GAD | 25141899 | Detail |
0.005 | hyperthyroidism | NA | GAD,LHGDN | Detail | |
0.120 | Hypotension, Orthostatic | NA | CTD_human | Detail | |
0.002 | hypothyroidism | NA | GAD | Detail | |
0.003 | male infertility | NA | BeFree,GAD | Detail | |
0.005 | Inflammation | NA | GAD,LHGDN | Detail | |
0.022 | Inflammatory Bowel Diseases | Contribution of MDR1 gene polymorphisms on IBD predisposition and response to gl... | BeFree,GAD,LHGDN | 25346426 | Detail |
0.022 | Inflammatory Bowel Diseases | More than 50 polymorphisms of the MDR-1 gene have been described; a subset of th... | BeFree,GAD,LHGDN | 25712147 | Detail |
<0.001 | influenza | NA | BeFree | Detail | |
<0.001 | Intestinal Diseases | Multi-drug resistance gene 1 (ABCB1) is closely related to bowel diseases. | BeFree | 25755800 | Detail |
<0.001 | irritable bowel syndrome | Contribution of MDR1 gene polymorphisms on IBD predisposition and response to gl... | BeFree | 25346426 | Detail |
0.003 | Creutzfeldt-Jakob disease | NA | LHGDN | Detail | |
<0.001 | kernicterus | NA | BeFree | Detail | |
0.003 | Kidney Diseases | NA | BeFree,GAD | Detail | |
<0.001 | Kidney Failure, Acute | NA | BeFree | Detail | |
0.083 | Kidney Failure, Chronic | NA | BeFree,GAD,RGD | Detail | |
0.123 | Kidney Neoplasm | NA | BeFree,CTD_human,GAD | Detail | |
0.083 | HIV Infections | Prevalence of MDR1 C3435T and CYP2B6 G516T polymorphisms among HIV-1 infected So... | BeFree | 22297601 | Detail |
0.003 | leiomyosarcoma | NA | BeFree,LHGDN | Detail | |
0.055 | leukemia | Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels ... | BeFree,GAD,LHGDN | 24954033 | Detail |
0.003 | kidney failure | The purpose of this study is to compare the genotype frequency of C3435T and G11... | BeFree | 17376299 | Detail |
0.003 | Acute Erythroblastic Leukemia | NA | BeFree,GAD | Detail | |
0.007 | lymphoid leukemia | NA | BeFree,GAD | Detail | |
0.010 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.002 | Acute Megakaryocytic Leukemias | NA | GAD | Detail | |
0.002 | acute monocytic leukemia | NA | GAD | Detail | |
0.073 | Leukemia, Myelocytic, Acute | Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogene... | BeFree,GAD,LHGDN | 24855032 | Detail |
0.073 | Leukemia, Myelocytic, Acute | Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment fo... | BeFree,GAD,LHGDN | 25558979 | Detail |
0.073 | Leukemia, Myelocytic, Acute | A median fluorescence intensity ratio (MFIR) which measures the efflux of mitoxa... | BeFree,GAD,LHGDN | 26002514 | Detail |
0.006 | myeloid leukemia | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Leukemia, Myeloid, Chronic-Phase | ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in... | BeFree,GAD | 25301112 | Detail |
0.002 | acute myelomonocytic leukemia | NA | GAD | Detail | |
<0.001 | prolymphocytic leukemia | NA | BeFree | Detail | |
0.009 | acute promyelocytic leukemia | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
0.006 | leukopenia | With respect to hematological and nonhematological toxicities, SNPs in drug tran... | BeFree,GAD | 25340731 | Detail |
<0.001 | lipoma | NA | BeFree | Detail | |
<0.001 | liposarcoma | These results show that bortezomib exhibits preferential cytotoxicity toward SW8... | BeFree | 25576094 | Detail |
<0.001 | liver cirrhosis | NA | BeFree | Detail | |
0.200 | Liver Cirrhosis, Experimental | NA | CTD_human,CTD_mouse | Detail | |
0.005 | Liver diseases | NA | GAD | Detail | |
0.007 | Liver neoplasms | NA | BeFree,LHGDN | Detail | |
0.003 | Chronic Obstructive Airway Disease | NA | BeFree,GAD | Detail | |
0.012 | Lung Neoplasms | NA | BeFree,LHGDN | Detail | |
0.003 | Lupus Erythematosus, Systemic | NA | BeFree,GAD | Detail | |
0.005 | lupus nephritis | NA | GAD | Detail | |
<0.001 | lymphadenitis | NA | BeFree | Detail | |
0.011 | lymphoma | Steroid derivatives were studied for their growth-inhibitory effect, cytotoxicit... | BeFree,LHGDN | 25862866 | Detail |
<0.001 | Lymphoma, Follicular | NA | BeFree | Detail | |
0.003 | Lymphoma, Non-Hodgkin | NA | BeFree,LHGDN | Detail | |
0.003 | Lymphoproliferative Disorders | NA | BeFree,GAD | Detail | |
0.003 | malaria | NA | BeFree,GAD | Detail | |
<0.001 | Malaria, Falciparum | NA | BeFree | Detail | |
<0.001 | Primary malignant neoplasm of liver | NA | BeFree | Detail | |
0.015 | Malignant neoplasm of stomach | Establishment and partial characterization of an epirubicin-resistant gastric ca... | BeFree,GAD | 25169536 | Detail |
0.015 | Malignant neoplasm of stomach | Association between ABCB1 immunohistochemical expression and overall survival in... | BeFree,GAD | 25169549 | Detail |
0.015 | Malignant neoplasm of stomach | Is the ABCB1 gene associated with the increased risk of gastric cancer developme... | BeFree,GAD | 25236528 | Detail |
0.015 | Malignant neoplasm of stomach | Manganese superoxide dismutase (MnSOD) has been shown to be associated with doxo... | BeFree,GAD | 25499851 | Detail |
0.015 | Malignant neoplasm of stomach | Acquisition of doxorubicin resistance facilitates migrating and invasive potenti... | BeFree,GAD | 25686905 | Detail |
0.122 | Marijuana Abuse | NA | CTD_human,GAD | Detail | |
0.001 | medulloblastoma | NA | BeFree | Detail | |
<0.001 | meningioma | NA | BeFree | Detail | |
<0.001 | Mesothelioma | NA | BeFree | Detail | |
<0.001 | Monosomy | NA | BeFree | Detail | |
0.032 | multiple myeloma | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | multiple sclerosis | NA | GAD | Detail | |
0.003 | myasthenia gravis | NA | BeFree,GAD | Detail | |
<0.001 | Myelodysplasia | NA | BeFree | Detail | |
<0.001 | Myeloproliferative disease | NA | BeFree | Detail | |
0.002 | Nasopharyngeal Neoplasms | NA | GAD | Detail | |
0.120 | Nausea | NA | CTD_human | Detail | |
<0.001 | Nausea and vomiting | NA | BeFree | Detail | |
<0.001 | neonatal abstinence syndrome | NA | BeFree | Detail | |
0.125 | Neoplasm Metastasis | NA | BeFree,CTD_human | Detail | |
0.002 | Pathologic Neovascularization | NA | GAD | Detail | |
0.002 | nephroblastoma | NA | BeFree | Detail | |
0.003 | nephrotic syndrome | NA | BeFree,GAD | Detail | |
0.120 | nervous system disorder | NA | BeFree,CTD_human | Detail | |
0.129 | neuroblastoma | The purpose of this project was to determine if the development of doxorubicin r... | BeFree,CTD_human,LHGDN | 25128389 | Detail |
0.130 | neutropenia | With respect to hematological and nonhematological toxicities, SNPs in drug tran... | BeFree,CTD_human,GAD | 25340731 | Detail |
0.005 | obesity | NA | BeFree,GAD | Detail | |
0.010 | Bone necrosis | NA | GAD,LHGDN | Detail | |
0.008 | osteosarcoma | Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in os... | BeFree | 25310700 | Detail |
0.008 | osteosarcoma | MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targetin... | BeFree | 25727016 | Detail |
0.008 | osteosarcoma | In conclusion, icariin possesses a reversal effect on multidrug resistance in MG... | BeFree | 25747987 | Detail |
0.015 | ovarian carcinoma | Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleo... | BeFree | 24810093 | Detail |
0.015 | ovarian carcinoma | This research provides some new information about doxorubicin resistance, indica... | BeFree | 25285166 | Detail |
0.015 | ovarian carcinoma | MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circu... | BeFree | 25687880 | Detail |
0.015 | ovarian carcinoma | Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel r... | BeFree | 25801244 | Detail |
0.015 | ovarian carcinoma | The MDR1 gene is a direct target of the Wnt/β-catenin signaling pathway, which p... | BeFree | 26053275 | Detail |
0.121 | Pain, Postoperative | NA | BeFree,CTD_human | Detail | |
0.003 | Pancreatic Neoplasm | NA | BeFree,GAD | Detail | |
0.150 | Parkinson disease | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.009 | Peptic Ulcer | ABCB1 expression in peptic ulcer patients and its connection with H. pylori Infe... | BeFree,GAD | 25117101 | Detail |
0.121 | Peripheral neuropathy | Seventeen polymorphisms in regulatory and coding regions of genes controlling VC... | BeFree,CTD_human | 25084203 | Detail |
0.003 | Pituitary Neoplasms | NA | LHGDN | Detail | |
0.001 | Adenomatous Polyposis Coli | NA | BeFree | Detail | |
0.002 | Postoperative Complications | NA | GAD | Detail | |
0.001 | Preleukemia | NA | BeFree | Detail | |
0.003 | Prostatic Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | psoriasis | A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment respon... | BeFree | 24889923 | Detail |
<0.001 | Psychotic Disorders | NA | BeFree | Detail | |
<0.001 | pyruvate carboxylase deficiency disease | NA | BeFree | Detail | |
0.003 | kidney failure | NA | BeFree,GAD | Detail | |
0.080 | Reperfusion Injury | NA | CTD_mouse | Detail | |
0.002 | Respiratory Distress Syndrome, Newborn | NA | GAD | Detail | |
<0.001 | Retroviridae Infections | NA | BeFree | Detail | |
0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | schizoaffective disorder | NA | BeFree | Detail | |
0.014 | schizophrenia | Effects of genetic polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the steady-stat... | BeFree,GAD | 24682161 | Detail |
0.164 | Seizures | NA | BeFree,CTD_mouse,GAD,RGD | Detail | |
<0.001 | organic sexual dysfunction | NA | BeFree | Detail | |
0.002 | Skin Neoplasms | NA | GAD | Detail | |
<0.001 | Splenic Neoplasms | NA | BeFree | Detail | |
0.080 | status epilepticus | NA | CTD_mouse | Detail | |
0.020 | Stomach Neoplasms | NA | GAD,LHGDN | Detail | |
0.008 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
<0.001 | Substance Withdrawal Syndrome | NA | BeFree | Detail | |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
0.002 | thrombosis | NA | GAD | Detail | |
<0.001 | Thyroid Diseases | NA | BeFree | Detail | |
0.002 | Tobacco use disorder | NA | GAD | Detail | |
0.120 | Chromosomal translocation | NA | CTD_human | Detail | |
0.002 | tuberculosis | NA | GAD | Detail | |
0.002 | Tuberculosis, Pulmonary | NA | GAD | Detail | |
0.003 | tuberous sclerosis | NA | BeFree,LHGDN | Detail | |
0.120 | Adverse reaction to drug | NA | CTD_human | Detail | |
0.002 | Genitourinary Neoplasms | NA | GAD | Detail | |
0.002 | Urologic Neoplasms | NA | GAD | Detail | |
0.002 | vasculitis | NA | GAD | Detail | |
<0.001 | viral hepatitis | NA | BeFree | Detail | |
0.121 | Vomiting | NA | BeFree,CTD_human | Detail | |
0.002 | Weight Gain | NA | GAD | Detail | |
0.041 | Malignant neoplasm of lung | Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; C... | BeFree | 17259654 | Detail |
0.009 | Carcinoma of lung | Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; C... | BeFree | 17259654 | Detail |
0.012 | Helicobacter Infections | NA | GAD | Detail | |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
0.122 | diffuse large B-cell lymphoma | P2RY12 and P2RY1 had the highest frequency for gene gain in LUSC (26.95 and 26.6... | BeFree,CTD_human | 25379720 | Detail |
<0.001 | Immunoblastic Large-Cell Lymphoma | NA | BeFree | Detail | |
0.003 | T-Cell Lymphoma | NA | BeFree,LHGDN | Detail | |
0.002 | Lymphoma, T-Cell, Cutaneous | NA | GAD | Detail | |
0.002 | peripheral T-cell lymphoma | NA | GAD | Detail | |
<0.001 | Lymphoma, AIDS-Related | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
0.002 | Ovarian Failure, Premature | NA | GAD | Detail | |
0.003 | cerebral amyloid angiopathy | NA | LHGDN | Detail | |
<0.001 | essential hypertension | ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chine... | BeFree | 24522199 | Detail |
<0.001 | Encephalopathies | NA | BeFree | Detail | |
<0.001 | Polydipsia | NA | BeFree | Detail | |
0.008 | acute leukemia | ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and re... | BeFree | 25921280 | Detail |
<0.001 | Chronic gastritis | NA | BeFree | Detail | |
<0.001 | Depressive Symptoms | NA | BeFree | Detail | |
<0.001 | Withdrawal Symptoms | NA | BeFree | Detail | |
<0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
<0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of lung | P2RY12 and P2RY1 had the highest frequency for gene gain in LUSC (26.95 and 26.6... | BeFree | 25379720 | Detail |
0.004 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Complex partial seizures | NA | BeFree | Detail | |
<0.001 | Chronic pain | NA | BeFree | Detail | |
<0.001 | Sensory neuropathy | With respect to hematological and nonhematological toxicities, SNPs in drug tran... | BeFree | 25340731 | Detail |
<0.001 | Central nervous system depression (disorder) | NA | BeFree | Detail | |
<0.001 | renal fibrosis | We investigated whether genetic polymorphisms affecting CYP3A5 and ABCB1 influen... | BeFree | 25521359 | Detail |
0.002 | Abnormal renal function | NA | GAD | Detail | |
<0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
0.002 | gastroparesis | NA | GAD | Detail | |
<0.001 | Drug withdrawal syndrome | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gallbladder | NA | BeFree | Detail | |
<0.001 | Malignant tumor of peritoneum | NA | BeFree | Detail | |
<0.001 | uterine cancer | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of brain | NA | GAD | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
0.030 | Malignant neoplasm of ovary | ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. | BeFree | 17828752 | Detail |
0.015 | ovarian carcinoma | ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. | BeFree | 17828752 | Detail |
<0.001 | acute myocardial infarction | NA | BeFree | Detail | |
<0.001 | Dermatitis, Phototoxic | NA | BeFree | Detail | |
0.002 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Liposarcoma, Pleomorphic | NA | BeFree | Detail | |
0.002 | hepatoblastoma | NA | BeFree | Detail | |
<0.001 | Neuroectodermal Tumor, Primitive | NA | BeFree | Detail | |
0.120 | adrenocortical carcinoma | NA | BeFree,CTD_human | Detail | |
<0.001 | Carcinoma, Lobular | NA | BeFree | Detail | |
<0.001 | mucoepidermoid carcinoma | NA | BeFree | Detail | |
0.002 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
0.122 | Neurotoxicity Syndromes | NA | CTD_human,GAD | Detail | |
<0.001 | gallbladder carcinoma | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Alcohol or Other Drugs use | ABCB1 has been implicated in substance use, and in post hoc tests we found that ... | BeFree | 25918995 | Detail |
<0.001 | pediatric AIDS | NA | BeFree | Detail | |
0.008 | Gastrointestinal Stromal Tumors | NA | GAD,LHGDN | Detail | |
0.002 | Cancer of Nasopharynx | NA | GAD | Detail | |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Interstitial fibrosis | In multivariate analysis, grafts carrying ABCB1 3435T allele(s) developed signif... | BeFree | 25521359 | Detail |
0.003 | Dyslipidemias | NA | BeFree,GAD | Detail | |
0.041 | Malignant neoplasm of lung | Inherited variation in the ATP-binding cassette transporter ABCB1 and survival a... | BeFree,GAD | 25122423 | Detail |
0.041 | Malignant neoplasm of lung | Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genet... | BeFree,GAD | 25667220 | Detail |
<0.001 | Drug usage | NA | BeFree | Detail | |
0.003 | Neoplasm, Residual | NA | BeFree,LHGDN | Detail | |
0.123 | Disease Progression | NA | CTD_human,LHGDN | Detail | |
<0.001 | parathyroid adenoma | NA | BeFree | Detail | |
<0.001 | Xeroderma pigmentosum, group B | NA | BeFree | Detail | |
<0.001 | 5,10-Methylenetetrahydrofolate reductase deficiency | NA | BeFree | Detail | |
<0.001 | Myoclonic Epilepsy, Juvenile | NA | BeFree | Detail | |
0.002 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Metastatic Renal Cell Cancer | Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patient... | BeFree | 24874929 | Detail |
<0.001 | Disseminated neuroblastoma | NA | BeFree | Detail | |
<0.001 | Recurrent Endometrial Cancer | NA | BeFree | Detail | |
0.003 | Cancer of Head and Neck | NA | BeFree,GAD | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
<0.001 | Philadelphia chromosome positive chronic myelogenous leukemia | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | extraosseous Ewings sarcoma-primitive neuroepithelial tumor | NA | BeFree | Detail | |
0.006 | Solid tumour | NA | BeFree,GAD | Detail | |
<0.001 | stage, ovarian epithelial cancer | NA | BeFree | Detail | |
0.002 | secondary acute myeloid leukemia | NA | BeFree | Detail | |
<0.001 | Papillary serous cystadenocarcinoma | NA | BeFree | Detail | |
<0.001 | malignant fibrous histiocytoma | NA | BeFree | Detail | |
<0.001 | anaplastic oligodendroglioma | NA | BeFree | Detail | |
0.001 | Adenocarcinoma of colon | Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells b... | BeFree | 26026084 | Detail |
<0.001 | uterine corpus sarcoma | In the present study, we used knockdown and overexpression approaches in the fol... | BeFree | 25596698 | Detail |
<0.001 | Impaired cognition | Cognitive impairment in major depressive disorder predicts poor treatment outcom... | BeFree | 25815420 | Detail |
<0.001 | Manic | NA | BeFree | Detail | |
<0.001 | Absence of pain sensation | The aim of this study was to investigate the significance of UGT2B7, OPRM1 and A... | BeFree | 24703092 | Detail |
0.004 | Malignant neoplasm of liver | NA | BeFree,GAD | Detail | |
<0.001 | Sarcoma of liver | NA | BeFree | Detail | |
<0.001 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of adrenal cortex | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Nonorganic psychosis | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.011 | Malignant neoplasm of prostate | EGFR mediates docetaxel resistance in human castration-resistant prostate cancer... | BeFree,GAD | 24888374 | Detail |
0.011 | Malignant neoplasm of prostate | Steroid derivatives were studied for their growth-inhibitory effect, cytotoxicit... | BeFree,GAD | 25862866 | Detail |
<0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
0.124 | Hematologic Neoplasms | NA | BeFree,CTD_human | Detail | |
<0.001 | Pouchitis | NA | BeFree | Detail | |
0.003 | Pancreatitis, Alcoholic | NA | BeFree,GAD | Detail | |
<0.001 | Steroid-sensitive nephrotic syndrome | NA | BeFree | Detail | |
<0.001 | Steroid-resistant nephrotic syndrome | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Insufficiency | Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development ... | BeFree | 25014506 | Detail |
<0.001 | neuropathy | NA | BeFree | Detail | |
0.003 | endometrial carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | hiv-infection/aids | NA | BeFree | Detail | |
0.080 | Sleep Apnea, Obstructive | NA | RGD | Detail | |
<0.001 | Postoperative Nausea | NA | BeFree | Detail | |
0.003 | Postoperative Nausea and Vomiting | NA | BeFree,GAD | Detail | |
<0.001 | Acute myeloid leukemia, minimal differentiation | NA | BeFree | Detail | |
<0.001 | Pervasive Development Disorder | NA | BeFree | Detail | |
<0.001 | Opiate Addiction | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
<0.001 | Palmar-plantar erythrodysesthesia syndrome | NA | BeFree | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | sexual dysfunction | NA | BeFree | Detail | |
<0.001 | Malignant melanoma of eye | NA | BeFree | Detail | |
<0.001 | primary sclerosing cholangitis | NA | BeFree | Detail | |
0.002 | Menopause present (finding) | NA | GAD | Detail | |
0.002 | Methotrexate poisoning | NA | GAD | Detail | |
0.006 | Osteosarcoma of bone | Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in os... | BeFree | 25310700 | Detail |
0.006 | Osteosarcoma of bone | MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targetin... | BeFree | 25727016 | Detail |
0.006 | Osteosarcoma of bone | In conclusion, icariin possesses a reversal effect on multidrug resistance in MG... | BeFree | 25747987 | Detail |
0.003 | Carcinogenesis | In conclusion, this study found that ABCC2 and ABCG2 expression levels were alte... | BeFree | 25793771 | Detail |
<0.001 | monocytic leukemia | NA | BeFree | Detail | |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
0.004 | prostate carcinoma | EGFR mediates docetaxel resistance in human castration-resistant prostate cancer... | BeFree | 24888374 | Detail |
0.004 | prostate carcinoma | Steroid derivatives were studied for their growth-inhibitory effect, cytotoxicit... | BeFree | 25862866 | Detail |
<0.001 | cocaine dependence | ABCB1 has been implicated in substance use, and in post hoc tests we found that ... | BeFree | 25918995 | Detail |
<0.001 | Carcinoma testes | NA | BeFree | Detail | |
0.002 | Hashimoto Disease | NA | GAD | Detail | |
0.006 | Epithelial ovarian cancer | NA | BeFree | Detail | |
<0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
0.002 | Refractory cancer | NA | BeFree | Detail | |
0.009 | Carcinoma of lung | Inherited variation in the ATP-binding cassette transporter ABCB1 and survival a... | BeFree | 25122423 | Detail |
0.009 | Carcinoma of lung | Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genet... | BeFree | 25667220 | Detail |
<0.001 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
0.013 | colon carcinoma | The expression of HIF-1α and MDR1/P-gp can be used as a predictive marker for ch... | BeFree | 24901645 | Detail |
0.013 | colon carcinoma | Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorub... | BeFree | 24901713 | Detail |
0.011 | stomach carcinoma | Establishment and partial characterization of an epirubicin-resistant gastric ca... | BeFree | 25169536 | Detail |
0.011 | stomach carcinoma | Association between ABCB1 immunohistochemical expression and overall survival in... | BeFree | 25169549 | Detail |
0.011 | stomach carcinoma | Is the ABCB1 gene associated with the increased risk of gastric cancer developme... | BeFree | 25236528 | Detail |
0.011 | stomach carcinoma | Manganese superoxide dismutase (MnSOD) has been shown to be associated with doxo... | BeFree | 25499851 | Detail |
0.011 | stomach carcinoma | Acquisition of doxorubicin resistance facilitates migrating and invasive potenti... | BeFree | 25686905 | Detail |
0.002 | Carcinoma of bladder | NA | BeFree | Detail | |
0.006 | Central neuroblastoma | The purpose of this project was to determine if the development of doxorubicin r... | BeFree | 25128389 | Detail |
0.002 | Disorder of macula of retina | NA | GAD | Detail | |
0.006 | Malignant neoplasm of kidney | NA | BeFree,GAD | Detail | |
<0.001 | cardiac event | NA | BeFree | Detail | |
<0.001 | central nervous system lymphoma | NA | BeFree | Detail | |
<0.001 | Febrile Neutropenia | NA | BeFree | Detail | |
<0.001 | early pregnancy | NA | BeFree | Detail | |
<0.001 | Sarcoma, metastatic | NA | BeFree | Detail | |
<0.001 | Brain Tumor, Primary | NA | BeFree | Detail | |
<0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Malignant Squamous Cell Neoplasm | NA | BeFree | Detail | |
0.001 | malignant peripheral nerve sheath tumor | NA | BeFree | Detail | |
<0.001 | Schizophrenia and related disorders | NA | BeFree | Detail | |
0.007 | Helicobacter pylori infection | ABCB1 expression in peptic ulcer patients and its connection with H. pylori Infe... | BeFree,GAD | 25117101 | Detail |
<0.001 | Sickle Cell Dactylitis | NA | BeFree | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
0.001 | Myelosuppression | NA | BeFree | Detail | |
<0.001 | Undifferentiated (Embryonal) Sarcoma | NA | BeFree | Detail | |
<0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
0.202 | Drug-Induced Liver Injury | NA | CTD_human,CTD_mouse,GAD | Detail | |
<0.001 | Pancolitis | NA | BeFree | Detail | |
0.002 | Cardiotoxicity | NA | GAD | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
0.006 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Ischemic stroke | ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopi... | BeFree | 25997249 | Detail |
<0.001 | Ovarian adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
0.002 | coronary restenosis | NA | GAD | Detail | |
<0.001 | Hurthle Cell Tumor | NA | BeFree | Detail | |
0.200 | Arthritis, Experimental | NA | CTD_human,RGD | Detail | |
0.004 | Drug Resistant Epilepsy | HIF-1α may have a regulatory effect on MDR1 expression in refractory epilepsy, w... | BeFree | 24590840 | Detail |
<0.001 | Stage 4S neuroblastoma | NA | BeFree | Detail | |
0.030 | Malignant neoplasm of ovary | Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleo... | BeFree,GAD | 24810093 | Detail |
0.030 | Malignant neoplasm of ovary | This research provides some new information about doxorubicin resistance, indica... | BeFree,GAD | 25285166 | Detail |
0.030 | Malignant neoplasm of ovary | MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circu... | BeFree,GAD | 25687880 | Detail |
0.030 | Malignant neoplasm of ovary | Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel r... | BeFree,GAD | 25801244 | Detail |
0.030 | Malignant neoplasm of ovary | The MDR1 gene is a direct target of the Wnt/β-catenin signaling pathway, which p... | BeFree,GAD | 26053275 | Detail |
<0.001 | Skin toxicity | NA | BeFree | Detail | |
<0.001 | High-Grade Prostatic Intraepithelial Neoplasia | NA | BeFree | Detail | |
0.121 | Squamous cell carcinoma of the head and neck | NA | BeFree,CTD_human | Detail | |
0.007 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Chronic leukemia (category) | NA | BeFree | Detail | |
<0.001 | X-Linked Combined Immunodeficiency Diseases | NA | BeFree | Detail | |
<0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Chronic myeloproliferative disorder | NA | BeFree | Detail | |
0.002 | Adenoma of large intestine | NA | GAD | Detail | |
<0.001 | M5b Acute differentiated monocytic leukemia | NA | BeFree | Detail | |
0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | NA | BeFree | Detail | |
<0.001 | Epithelioma | More than 50 polymorphisms of the MDR-1 gene have been described; a subset of th... | BeFree | 25712147 | Detail |
<0.001 | Undifferentiated leukemia | NA | BeFree | Detail | |
0.002 | renal carcinoma | NA | BeFree | Detail | |
0.162 | Mammary Neoplasms | Taken together, our data indicate that breast tumors with alveolar structures po... | BeFree,CTD_human,LHGDN | 24736530 | Detail |
0.162 | Mammary Neoplasms | Survivin family proteins as novel molecular determinants of doxorubicin resistan... | BeFree,CTD_human,LHGDN | 24886669 | Detail |
<0.001 | Hippocampal sclerosis | NA | BeFree | Detail | |
<0.001 | Primary Peritoneal Carcinoma | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.045 | colorectal cancer | Chemoresistance in multidrug-resistant (MDR) cells over expressing P-glycoprotei... | BeFree,GAD | 24901713 | Detail |
0.045 | colorectal cancer | Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 ge... | BeFree,GAD | 25355168 | Detail |
<0.001 | Phototoxicity | NA | BeFree | Detail | |
<0.001 | Neoplasms, Intracranial | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Diseases | Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development ... | BeFree | 25014506 | Detail |
0.003 | Renal Insufficiency | NA | BeFree,GAD | Detail | |
<0.001 | Sphenoid Wing Meningioma | NA | BeFree | Detail | |
0.005 | Delayed Graft Function | NA | GAD | Detail | |
<0.001 | Glioblastoma multiforme | Temozolomide resistance occurred through a biphasic response; first, by a confor... | BeFree | 25053824 | Detail |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | androgen independent prostate cancer | NA | BeFree | Detail | |
0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
<0.001 | Nephrotic Syndrome, Minimal Change | MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: prelimi... | BeFree | 25559283 | Detail |
<0.001 | prostatic hypertrophy | NA | BeFree | Detail | |
<0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
<0.001 | Glucocorticoid Receptor Deficiency | NA | BeFree | Detail | |
<0.001 | Nonmedullary thyroid carcinoma, with or without cell oxyphilia | NA | BeFree | Detail | |
<0.001 | uterine corpus cancer | NA | BeFree | Detail | |
0.006 | coronary artery disease | NA | BeFree,GAD | Detail | |
<0.001 | Cardiac Carcinoma | NA | BeFree | Detail | |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
0.160 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Acute postoperative pain | Our preliminary results support the evidence that OPRM1/ABCB1 genotypes along wi... | BeFree | 25809606 | Detail |
0.143 | liver carcinoma | Association between the c.1564A>T genetic polymorphism of the MDR1 gene and hepa... | BeFree,CTD_human,LHGDN | 25177961 | Detail |
0.143 | liver carcinoma | Yet median expression of OCT1, OCT3, and MDR1 in HCC was significantly lower (1.... | BeFree,CTD_human,LHGDN | 25231932 | Detail |
0.143 | liver carcinoma | Taken together, we clarify that ZHX2 represses NF-Y-mediated activation of MDR1 ... | BeFree,CTD_human,LHGDN | 25473899 | Detail |
0.200 | inflammatory bowel disease 13 | NA | CTD_human,MGD | Detail | |
0.002 | Weight Gain Adverse Event | NA | GAD | Detail | |
0.002 | Chronic ulcerative colitis | NA | GAD | Detail | |
<0.001 | Clear-cell metastatic renal cell carcinoma | NA | BeFree | Detail | |
<0.001 | Early-Stage Breast Carcinoma | NA | BeFree | Detail | |
0.002 | Hypotension Adverse Event | NA | GAD | Detail | |
<0.001 | Ischemic Cerebrovascular Accident | ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopi... | BeFree | 25997249 | Detail |
0.004 | myelodysplastic syndrome | NA | BeFree,LHGDN | Detail | |
<0.001 | plasmablastic lymphoma | NA | BeFree | Detail | |
<0.001 | Juvenile arthritis | NA | BeFree | Detail | |
<0.001 | Progressive cGVHD | NA | BeFree | Detail | |
<0.001 | Triple Negative Breast Neoplasms | Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast c... | BeFree | 25140317 | Detail |
<0.001 | Breast cancer, lobular | NA | BeFree | Detail | |
0.002 | Infection | NA | GAD | Detail | |
<0.001 | juvenile rheumatoid arthritis | NA | BeFree | Detail | |
<0.001 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
0.005 | acquired immunodeficiency syndrome | NA | GAD | Detail | |
0.002 | Addison Disease | NA | GAD | Detail | |
0.015 | adenocarcinoma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | adenoma | NA | BeFree | Detail | |
<0.001 | Adult Antisocial Behavior | Genome-wide association data suggest ABCB1 and immune-related gene sets may be i... | BeFree | 25918995 | Detail |
<0.001 | agranulocytosis | NA | BeFree | Detail | |
0.002 | Alcoholic Intoxication, Chronic | NA | GAD | Detail | |
0.002 | Amnesia | NA | GAD | Detail | |
<0.001 | Fabry disease | NA | BeFree | Detail | |
<0.001 | anorexia nervosa | NA | BeFree | Detail | |
<0.001 | Anxiety Disorders | NA | BeFree | Detail | |
0.134 | rheumatoid arthritis | Multidrug resistance protein-1 expression, function and polymorphisms in patient... | BeFree,CTD_human,GAD | 24734954 | Detail |
0.134 | rheumatoid arthritis | ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect rena... | BeFree,CTD_human,GAD | 25817604 | Detail |
<0.001 | Asthenia | NA | BeFree | Detail | |
0.003 | asthma | NA | BeFree,GAD | Detail | |
0.002 | autistic disorder | NA | GAD | Detail | |
0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
0.003 | Balkan nephropathy | NA | BeFree,LHGDN | Detail | |
0.120 | Mental disorders | NA | CTD_human | Detail | |
<0.001 | bipolar disorder | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
<0.001 | Blast Phase | NA | BeFree | Detail | |
0.002 | Blood Coagulation Disorders | NA | GAD | Detail | |
0.005 | Brain Neoplasms | NA | BeFree,GAD | Detail | |
<0.001 | cannabis dependence | NA | BeFree | Detail | |
<0.001 | Carcinoid Tumor | NA | BeFree | Detail | |
0.008 | Malignant tumor of colon | The expression of HIF-1α and MDR1/P-gp can be used as a predictive marker for ch... | BeFree | 24901645 | Detail |
0.008 | Malignant tumor of colon | Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorub... | BeFree | 24901713 | Detail |
<0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
<0.001 | Bronchioloalveolar Adenocarcinoma | NA | BeFree | Detail | |
0.127 | Non-small cell lung carcinoma | NA | BeFree,CTD_human | Detail | |
0.011 | renal cell carcinoma | NA | BeFree,GAD,LHGDN | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ATP binding cassette transporter 1 (ABCB1) plays a critical role in the development and progression ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of ABCB1 polymorphisms and ulcerative colitis susceptibility. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Chemoresistance in multidrug-resistant (MDR) cells over expressing P-glycoprotein (P-gp) encoded by ... | DisGeNET | Detail |
Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polymorphisms of MDR1 are associated with patient's GC response and a predisposition to CD in Chines... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in gliobl... | DisGeNET | Detail |
Taken together, we confirmed P-gp targeting of TMZ, a crucial regulator of TMZ resistance in GBM. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Maternal medication use, fetal 3435 C>T polymorphism of the ABCB1 gene, and risk of isolated septal ... | DisGeNET | Detail |
In conclusion, fetal 3435 C>T polymorphism in the ABCB1 gene increases the risk for isolated septal ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The mRNA expression and function of OATP1B1, ABCB1 and ABCG2 were assessed in peripheral blood monon... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We hypothesized that the C(3435)T polymorphism in MDR-1 could be associated with resistant hypertens... | DisGeNET | Detail |
Recent data indicate that enzymes and transporters involved in CNI pharmacokinetics and pharmacodyna... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Contribution of MDR1 gene polymorphisms on IBD predisposition and response to glucocorticoids in IBD... | DisGeNET | Detail |
More than 50 polymorphisms of the MDR-1 gene have been described; a subset of these has been shown t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Multi-drug resistance gene 1 (ABCB1) is closely related to bowel diseases. | DisGeNET | Detail |
Contribution of MDR1 gene polymorphisms on IBD predisposition and response to glucocorticoids in IBD... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Prevalence of MDR1 C3435T and CYP2B6 G516T polymorphisms among HIV-1 infected South African patients... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 i... | DisGeNET | Detail |
The purpose of this study is to compare the genotype frequency of C3435T and G1199A polymorphisms in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myelo... | DisGeNET | Detail |
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leuk... | DisGeNET | Detail |
A median fluorescence intensity ratio (MFIR) which measures the efflux of mitoxantrone (an ATP Bindi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients w... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
With respect to hematological and nonhematological toxicities, SNPs in drug transporters (ABCB1 and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results show that bortezomib exhibits preferential cytotoxicity toward SW872-S cells possibly ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Steroid derivatives were studied for their growth-inhibitory effect, cytotoxicity, reversal of multi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Establishment and partial characterization of an epirubicin-resistant gastric cancer cell line with ... | DisGeNET | Detail |
Association between ABCB1 immunohistochemical expression and overall survival in gastric cancer pati... | DisGeNET | Detail |
Is the ABCB1 gene associated with the increased risk of gastric cancer development?--preliminary res... | DisGeNET | Detail |
Manganese superoxide dismutase (MnSOD) has been shown to be associated with doxorubicin resistance i... | DisGeNET | Detail |
Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cance... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The purpose of this project was to determine if the development of doxorubicin resistance is associa... | DisGeNET | Detail |
With respect to hematological and nonhematological toxicities, SNPs in drug transporters (ABCB1 and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells. | DisGeNET | Detail |
MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated prot... | DisGeNET | Detail |
In conclusion, icariin possesses a reversal effect on multidrug resistance in MG-63/DOX cells throug... | DisGeNET | Detail |
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms i... | DisGeNET | Detail |
This research provides some new information about doxorubicin resistance, indicating that mitochondr... | DisGeNET | Detail |
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel res... | DisGeNET | Detail |
Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human o... | DisGeNET | Detail |
The MDR1 gene is a direct target of the Wnt/β-catenin signaling pathway, which plays an important ro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 expression in peptic ulcer patients and its connection with H. pylori Infection. | DisGeNET | Detail |
Seventeen polymorphisms in regulatory and coding regions of genes controlling VCR targets (TUBB1, MA... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Effects of genetic polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the steady-state plasma concentrati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR... | DisGeNET | Detail |
Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
P2RY12 and P2RY1 had the highest frequency for gene gain in LUSC (26.95 and 26.68%, respectively) wh... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with ess... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
P2RY12 and P2RY1 had the highest frequency for gene gain in LUSC (26.95 and 26.68%, respectively) wh... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
With respect to hematological and nonhematological toxicities, SNPs in drug transporters (ABCB1 and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We investigated whether genetic polymorphisms affecting CYP3A5 and ABCB1 influence EMT and kidney fi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. | DisGeNET | Detail |
ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 has been implicated in substance use, and in post hoc tests we found that variation in ABCB1 w... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In multivariate analysis, grafts carrying ABCB1 3435T allele(s) developed significantly less EMT and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy fo... | DisGeNET | Detail |
Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is as... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines. | DisGeNET | Detail |
In the present study, we used knockdown and overexpression approaches in the following set of uterin... | DisGeNET | Detail |
Cognitive impairment in major depressive disorder predicts poor treatment outcome, but ABCB1 genetic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the significance of UGT2B7, OPRM1 and ABCB1 polymorphisms f... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dep... | DisGeNET | Detail |
Steroid derivatives were studied for their growth-inhibitory effect, cytotoxicity, reversal of multi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney di... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells. | DisGeNET | Detail |
MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated prot... | DisGeNET | Detail |
In conclusion, icariin possesses a reversal effect on multidrug resistance in MG-63/DOX cells throug... | DisGeNET | Detail |
In conclusion, this study found that ABCC2 and ABCG2 expression levels were altered already in mild/... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dep... | DisGeNET | Detail |
Steroid derivatives were studied for their growth-inhibitory effect, cytotoxicity, reversal of multi... | DisGeNET | Detail |
ABCB1 has been implicated in substance use, and in post hoc tests we found that variation in ABCB1 w... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy fo... | DisGeNET | Detail |
Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is as... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression of HIF-1α and MDR1/P-gp can be used as a predictive marker for chemotherapy resistanc... | DisGeNET | Detail |
Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulati... | DisGeNET | Detail |
Establishment and partial characterization of an epirubicin-resistant gastric cancer cell line with ... | DisGeNET | Detail |
Association between ABCB1 immunohistochemical expression and overall survival in gastric cancer pati... | DisGeNET | Detail |
Is the ABCB1 gene associated with the increased risk of gastric cancer development?--preliminary res... | DisGeNET | Detail |
Manganese superoxide dismutase (MnSOD) has been shown to be associated with doxorubicin resistance i... | DisGeNET | Detail |
Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cance... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The purpose of this project was to determine if the development of doxorubicin resistance is associa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 expression in peptic ulcer patients and its connection with H. pylori Infection. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese is... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HIF-1α may have a regulatory effect on MDR1 expression in refractory epilepsy, which is probably con... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms i... | DisGeNET | Detail |
This research provides some new information about doxorubicin resistance, indicating that mitochondr... | DisGeNET | Detail |
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel res... | DisGeNET | Detail |
Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human o... | DisGeNET | Detail |
The MDR1 gene is a direct target of the Wnt/β-catenin signaling pathway, which plays an important ro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
More than 50 polymorphisms of the MDR-1 gene have been described; a subset of these has been shown t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, our data indicate that breast tumors with alveolar structures possess resistance to ... | DisGeNET | Detail |
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic hu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Chemoresistance in multidrug-resistant (MDR) cells over expressing P-glycoprotein (P-gp) encoded by ... | DisGeNET | Detail |
Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney di... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Temozolomide resistance occurred through a biphasic response; first, by a conformational change in P... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our preliminary results support the evidence that OPRM1/ABCB1 genotypes along with age, weight and d... | DisGeNET | Detail |
Association between the c.1564A>T genetic polymorphism of the MDR1 gene and hepatocellular carcinoma... | DisGeNET | Detail |
Yet median expression of OCT1, OCT3, and MDR1 in HCC was significantly lower (1.4-, 2.7-, and 2-fold... | DisGeNET | Detail |
Taken together, we clarify that ZHX2 represses NF-Y-mediated activation of MDR1 transcription and, i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese is... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genome-wide association data suggest ABCB1 and immune-related gene sets may be involved in adult ant... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid ar... | DisGeNET | Detail |
ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patien... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression of HIF-1α and MDR1/P-gp can be used as a predictive marker for chemotherapy resistanc... | DisGeNET | Detail |
Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386545618 dbSNP
- Genome
- hg19
- Position
- chr7:87,132,333-87,342,639
- Variant Type
- snv
Genome browser